Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Primary Total Knee Arthroplasty
NCT05919615Completed
- Sponsor
- Damascus University
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in knee osteoarthritis (OA) comparing Intravenous Tranexamic Acid with Placebo (2 arms). Primary endpoints: Total Blood Loss at 72 hours, Intra-operative Blood Loss at 1 hour and 2 more. Started Jul 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05919615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919615.